Jillian F. Wise

  • Visiting postdoc, Broad Institute/ Mass General Hospital; PhD

Publications 2022

Stanzione M, Zhong J, Wong E, LaSalle TJ, Wise JF, Simoneau A, Myers DT, Phat S, Sade-Feldman M, Lawrence MS, Hadden MK, Zou L, Farago AF, Dyson NJ, Drapkin BJ (2022)
Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer
Sci Adv, 8 (19), eabn1229
DOI 10.1126/sciadv.abn1229, PubMed 35559669

Publications 2021

Langenbucher A, Bowen D, Sakhtemani R, Bournique E, Wise JF, Zou L, Bhagwat AS, Buisson R, Lawrence MS (2021)
An extended APOBEC3A mutation signature in cancer
Nat Commun, 12 (1), 1602
DOI 10.1038/s41467-021-21891-0, PubMed 33707442

Publications 2020

Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H (2020)
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
Blood Adv, 4 (9), 1859-1866
DOI 10.1182/bloodadvances.2019001325, PubMed 32374878

Publications 2019

Steen CB, Leich E, Myklebust JH, Lockmer S, Wise JF, Wahlin BE, Østenstad B, Liestøl K, Kimby E, Rosenwald A, Smeland EB, Holte H, Lingjærde OC, Brodtkorb M (2019)
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy
Haematologica, 104 (10), e460-e464
DOI 10.3324/haematol.2018.209080, PubMed 30846496

Wise JF, Lawrence MS (2019)
Huge whole-genome study of human metastatic cancers
Nature, 575 (7781), 60-61
DOI 10.1038/d41586-019-03123-0, PubMed 31690848

Publications 2017

Jain N, Zhu H, Khashab T, Ye Q, George B, Mathur R, Singh RK, Berkova Z, Wise JF, Braun FK, Wang X, Patel K, Xu-Monette ZY, Courty J, Young KH, Sehgal L, Samaniego F (2017)
Targeting nucleolin for better survival in diffuse large B-cell lymphoma
Leukemia, 32 (3), 663-674
DOI 10.1038/leu.2017.215, PubMed 28690315

Publications 2014

Berkova Z, Wang S, Ao X, Wise JF, Braun FK, Rezaeian AH, Sehgal L, Goldenberg DM, Samaniego F (2014)
CD74 interferes with the expression of fas receptor on the surface of lymphoma cells
J Exp Clin Cancer Res, 33 (1), 80
DOI 10.1186/s13046-014-0080-y, PubMed 25304249

Sehgal L, Mathur R, Braun FK, Wise JF, Berkova Z, Neelapu S, Kwak LW, Samaniego F (2014)
FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma
Leukemia, 28 (12), 2376-87
DOI 10.1038/leu.2014.126, PubMed 24811343

Publications 2013

Wise JF, Berkova Z, Mathur R, Zhu H, Braun FK, Tao RH, Sabichi AL, Ao X, Maeng H, Samaniego F (2013)
Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
Blood, 121 (23), 4729-39
DOI 10.1182/blood-2012-12-471094, PubMed 23599269

Publications 2012

Daniluk U, Kerros C, Tao RH, Wise JF, Ao X, Berkova Z, Samaniego F (2012)
The peptide derived from the Ig-like domain of human herpesvirus 8 K1 protein induces death in hematological cancer cells
J Exp Clin Cancer Res, 31 (1), 69
DOI 10.1186/1756-9966-31-69, PubMed 22929310

Publications 2011

Tao RH, Berkova Z, Wise JF, Rezaeian AH, Daniluk U, Ao X, Hawke DH, Karp JE, Lin HK, Molldrem JJ, Samaniego F (2011)
PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo
Blood, 118 (11), 3107-18
DOI 10.1182/blood-2011-04-349670, PubMed 21803845

Publications 2009

Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F (2009)
Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein
J Natl Cancer Inst, 101 (6), 399-411
DOI 10.1093/jnci/djn516, PubMed 19276446

Page visits: 6165